Company Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-03-17 pm EDT			5-day change	1st Jan Change
10.12 ^USD	+0.50%		+5.42%	-26.19%

Mar. 12	Sector Update: Health Care Stocks Lower Late Afternoon	MT
Mar. 12	Myriad Genetics Shares Rise After Upgrade From Piper Sandler	MT

Business description: Myriad Genetics, Inc.

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Companyâs testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight, among others.

Number of employees: 2,700

Sales by Activity: Myriad Genetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
Biotechnology	-	691M	678M	753M	838M
Other	56.2M	-	-	-	-
Diagnostics	543M	-	-	-	-

See all business segments

Geographical breakdown of sales: Myriad Genetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
United States	551M	604M	592M	118M	770M
Rest of world	48.8M	86.9M	86.9M	1.3M	68.1M

See all geographic segments

Executive Committee: Myriad Genetics, Inc.

Manager	Title	Age	Since
Paul Diaz CEO	Chief Executive Officer	62	2020-08-12
Scott Leffler DFI	Director of Finance/CFO	50	2024-01-28
Thomas P. Slavin CTO	Chief Tech/Sci/R&D Officer	-	2021-06-15
Samraat Raha COO	Chief Operating Officer	53	2023-12-10
Kevin Haas CTO	Chief Tech/Sci/R&D Officer	39	2021-01-31

See MYRIAD GENETICS, INC. governance

Composition of the Board of Directors: Myriad Genetics, Inc.

Director	Title	Age	Since
S. Phanstiel CHM	Chairman	66	2020-03-22
Heiner Dreismann BRD	Director/Board Member	70	2010-06-09
Colleen Reitan BRD	Director/Board Member	65	2019-09-24
Lee Newcomer BRD	Director/Board Member	72	2019-09-24
Dan Spiegelman BRD	Director/Board Member	66	2020-05-26
Daniel Skovronsky BRD	Director/Board Member	51	2020-07-20
Paul Diaz BRD	Director/Board Member	62	2020-08-12
Rashmi Kumar BRD	Director/Board Member	54	2020-09-09
Paul Bisaro BRD	Director/Board Member	64	2022-10-30
Mark S. Davis BRD	Director/Board Member	-	2024-12-09

Composition of the Board of Directors

Shareholders: Myriad Genetics, Inc.

Name	Equities	%	Valuation
BlackRock Advisors LLC 16.5 %	15,016,282	16.5 %	161 M $
Vanguard Fiduciary Trust Co. 11.63 %	10,591,043	11.63 %	114 M $
Wellington Trust Co., NA 6.596 %	6,004,598	6.596 %	64 M $
STATE STREET CORPORATION 6.07 %	5,525,705	6.07 %	59 M $
Millennium Management LLC 4.773 %	4,345,196	4.773 %	47 M $

List of MYRIAD GENETICS, INC. shareholders

Company details: Myriad Genetics, Inc.

Myriad Genetics, Inc.

322 North 2200 West

84116, Salt Lake City

+801 584 3600

http://www.myriad.com

Diagnostic & Testing Substances

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MYRIAD GENETICS, INC.	+0.50%	+5.42%	-52.17%	-59.90%	919M
BIOMÉRIEUX	+0.44%	-2.30%	+17.63%	+19.86%	14.69B
LANTHEUS HOLDINGS, INC.	+1.64%	-6.59%	+76.65%	+87.01%	6.92B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.92%	-1.23%	-27.36%	+69.39%	6.46B
DIASORIN S.P.A.	0.00%	-5.69%	+3.75%	-30.84%	5.54B
GUARDANT HEALTH, INC.	+0.02%	+19.70%	+141.83%	-23.15%	5.29B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.24%	+1.29%	-31.41%	-8.63%	3.35B
ANDON HEALTH CO., LTD.	-0.80%	-0.45%	-0.80%	-29.24%	2.71B
VITROLIFE AB	-1.17%	+7.09%	-9.98%	-44.61%	2.39B
SANSURE BIOTECH INC.	-4.76%	-4.24%	+18.76%	-18.90%	2.04B
Average	-0.30%	+1.77%	+13.69%	-3.90%	5.03B
Weighted average by Cap.	+0.21%	+0.61%	+24.72%	+14.73%